A customized approach to mRNA manufacturing

Participate in this webinar to gain insights into methods for furthering mRNA production programs and learn how to identify areas for development and streamline processes.

Register Free: https://www.biopharminternational.com/bp_w/customized-approach

Event Overview:

Diversity in mRNA therapies has mitigated advancements in the processes for manufacturing. IVT and capping reactions are not universal and must be finely tuned to each molecule based on composition, structure, and size. Using literature and experimental design, adapting each method to fit the molecule is necessary for hastening the optimization of mRNA development. In this webinar, you will gain insights into:

• Subject examination
• Identifying vital methodologies
• Refining and focusing target components
• Proper in-process analytics

Key Learning Objectives

• Identifying the variable/critical components involved in the mRNA production process
• Understanding the reasoning behind revisiting procedures
• Learning what metrics to use to navigate the mRNA process development

Who Should Attend

• Students/Researchers interested in developing better methods of in vitro transcribed RNA manufacturing

Speaker

Scott Alderucci
Director of mRNA Process Development & GMP operations
Curia Global, Inc.

Scott Alderucci is the director of process development overseeing the Process Development and GMP divisions of mRNA at Curia. He holds a scientific master’s degree and has 25 years of experience working in the field of biologics focused on DNA, mRNA and antibody platforms. He has worked within such institutions as Millennium Pharmaceuticals, Cellular Genomics, the State of Massachusetts, and Shire Pharmaceuticals prior to joining Curia. His current role is focused on providing research and development through GMP level production of a wide range of mRNA products to meet various program goals.

Register Free: https://www.biopharminternational.com/bp_w/customized-approach